Podcast: Spray Away Severe Depression
Dr. Caleb Battersby, UConn Health's director of interventional psychiatry, explains a treatment approach to severe depression that's providing hope
A form of ketamine delivered as a nasal spray is showing effectiveness in treating severe depression. The FDA has approved esketamine for adults with treatment-resistant depression; the patient self-administers it in a supervised clinical setting.
Dr. Caleb Battersby, director of interventional psychiatry at UConn Health, joins the UConn Health Pulse podcast to explain how it works and why it’s providing hope for patients who haven’t had success with other treatments.
It can translate into people being able to kind of make lifestyle changes probably more quickly and more effectively than they do with oral medications. — Dr. Caleb Battersby
Listen now:
Latest UConn Today
- Powering the Next Generation of Quantum TechnologyUConn is a partner in a project to develop a deeper understanding of how a revolutionary chip fabrication process can improve superconducting qubits
- Winners of Faculty Spotlight Spring 2025 AwardsUConn School of Medicine Honors its Faculty Members Yulan Xiong, Caleb Battersby, and Audrey Chapman
- School of Nursing Class of 2025, Reflects on Their Time as a HuskyQ&A with graduating senior Allison Villano
- Chinenye Anyanwu Named the 2025 School of Pharmacy Faculty Service Award RecipientThe School of Pharmacy Dean Robert L. McCarthy Faculty Service award is presented to a full-time faculty member who has provided outstanding service to their department, school, the University, the profession of pharmacy, and the public. This year, the recipient of the prestigious award is Chinenye Anyanwu!
- Congratulations Class of 2025Commencement is more than a ceremony—it’s a defining moment
- The Last FourInspiring. Impactful. Unforgettable.
